Threonine Aspartase1: An unexplored protease with relevance for oral oncology?

Oral Oncol. 2016 Mar:54:e10-2. doi: 10.1016/j.oraloncology.2015.12.005. Epub 2016 Jan 6.

¹ ENT Department, Molecular and Cellular Oncology, University Hospital of Mainz, Mainz, Germany. Electronic address: [email protected].
² ENT Department, Molecular and Cellular Oncology, University Hospital of Mainz, Mainz, Germany. Electronic address: [email protected].
³ ENT Department, Molecular and Cellular Oncology, University Hospital of Mainz, Mainz, Germany. Electronic address: [email protected].
⁴ ENT Department, Molecular and Cellular Oncology, University Hospital of Mainz, Mainz, Germany. Electronic address: [email protected].
⁵ ENT Department, Molecular and Cellular Oncology, University Hospital of Mainz, Mainz, Germany. Electronic address: [email protected].

No abstract available

Keywords: Biomarker; Head and neck cancer; Proteases; Targeted therapy; Taspase1; Therapy resistance.

Publication types